Alternative splicing of interleukin-7 (IL-7) and interleukin-7 receptor alpha (IL-7Rα) in peripheral blood from patients with multiple sclerosis (MS)

Journal of Neuroimmunology

Volumn 222, Issue 1-2, 2010, Pages 82-86

  Rane, Lalit ^a,b   Vudattu, Nalini ^a   Bourcier, Kasia ^c   Graniar, Eva ^a   Hillert, Jan ^a   Seyfert, Vicki ^c   Maeurer, M J ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alternative splicing; CD127; IL 7 receptor; Interleukin 7; MS; T cells

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; BASE SEQUENCE; BIOLOGICAL MARKERS; DNA MUTATIONAL ANALYSIS; EXONS; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC TESTING; HUMANS; INTERLEUKIN-7; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RECEPTORS, INTERLEUKIN-7; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 77952289509     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.02.014     Document Type: Article

References (19)

1. Al-Rawi M.A., Rmali K., Mansel R.E., Jiang W.G. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway. Br. J. Surg. 2004, 91:61-68.
2. Atamas S.P., Choi J., Yurovsky V.V., White B. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol. 1996, 156:435-441.
3. Benjamin D., Sharma V., Knobloch T.J., Armitage R.J., Dayton M.A., Goodwin R.G. B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors. J. Immunol. 1994, 152:4749-4757.
4. Booth D.R., Arthur A.T., Teutsch S.M., Bye C., Rubio J., Armati P.J., Pollard J.D., Heard R.N., Stewart G.J. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J. Mol. Med. 2005, 83:822-830.
5. Fry T.J., Mackall C.L. Interleukin-7: from bench to clinic. Blood 2002, 99:3892-3904.
6. Goodwin R.G., Lupton S., Schmierer A., Hjerrild K.J., Jerzy R., Clevenger W., Gillis S., Cosman D., Namen A.E. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:302-306.
7. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., Caillier S.J., Ban M., Goris A., Barcellos L.F., Lincoln R., McCauley J.L., Sawcer S.J., Compston D.A., Dubois B., Hauser S.L., Garcia-Blanco M.A., Pericak-Vance M.A., Haines J.L. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat. Genet. 2007, 39:1083-1091.
8. Heaney M.L., Golde D.W. Soluble cytokine receptors. Blood 1996, 87:847-857.
9. Houseley J., Tollervey D. The many pathways of RNA degradation. Cell 2009, 136:763-776.
10. Korte A., Moricke A., Beyermann B., Kochling J., Taube T., Kebelmann-Betzing C., Henze G., Seeger K. Extensive alternative splicing of interleukin-7 in malignant hematopoietic cells: implication of distinct isoforms in modulating IL-7 activity. J. Interferon Cytokine Res. 1999, 19:495-503.
11. Krawczenko A., Kieda C., Dus D. The biological role and potential therapeutic application of interleukin 7. Arch. Immunol. Ther. Exp. (Warsz) 2005, 53:518-525.
12. Lundmark F., Duvefelt K., Iacobaeus E., Kockum I., Wallstrom E., Khademi M., Oturai A., Ryder L.P., Saarela J., Harbo H.F., Celius E.G., Salter H., Olsson T., Hillert J. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat. Genet. 2007, 39:1108-1113.
13. Rose T., Lambotte O., Pallier C., Delfraissy J.F., Colle J.H. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients. J. Immunol. 2009, 182:7389-7397.
14. Scupoli M.T., Perbellini O., Krampera M., Vinante F., Cioffi F., Pizzolo G. Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. Haematologica 2007, 92:264-266.
15. Sorg R.V., McLellan A.D., Hock B.D., Fearnley D.B., Hart D.N. Human dendritic cells express functional interleukin-7. Immunobiology 1998, 198:514-526.
16. Tsytsikov V.N., Yurovsky V.V., Atamas S.P., Alms W.J., White B. Identification and characterization of two alternative splice variants of human interleukin-2. J. Biol. Chem. 1996, 271:23055-23060.
17. Vudattu N.K., Kuhlmann-Berenzon S., Khademi M., Seyfert V., Olsson T., Maeurer M.J. Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+T-cells in patients with autoimmune diseases affecting the central nervous system. PLoS ONE 2009, 4:e6534.
18. Vudattu N.K., Magalhaes I., Hoehn H., Pan D., Maeurer M.J. Expression analysis and functional activity of interleukin-7 splice variants. Genes Immun. 2009, 10:132-140.
19. Yamanaka K., Clark R., Rich B., Dowgiert R., Hirahara K., Hurwitz D., Shibata M., Mirchandani N., Jones D.A., Goddard D.S., Eapen S., Mizutani H., Kupper T.S. Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma. Blood 2006, 107:2440-2445.